Am. J. Respir. Crit. Care Med.,
Volume 160, Number 6, December 1999, 1862-1868
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
M. M. del Giudice, A. Pezzulo, C. Capristo, E. Alterio, S. Caggiano, D. de Benedictis, and A. F. Capristo Leukotriene modifiers in the treatment of asthma in children Therapeutic Advances in Respiratory Disease, October 1, 2009; 3(5): 245 - 251. [Abstract] [PDF] |
||||
![]() |
H. K. Reddel, D. R. Taylor, E. D. Bateman, L.-P. Boulet, H. A. Boushey, W. W. Busse, T. B. Casale, P. Chanez, P. L. Enright, P. G. Gibson, et al. An Official American Thoracic Society/European Respiratory Society Statement: Asthma Control and Exacerbations: Standardizing Endpoints for Clinical Asthma Trials and Clinical Practice Am. J. Respir. Crit. Care Med., July 1, 2009; 180(1): 59 - 99. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Bjermer Review: Evaluating combination therapies for asthma: pros, cons, and comparative benefits Therapeutic Advances in Respiratory Disease, June 1, 2008; 2(3): 149 - 161. [Abstract] [PDF] |
||||
![]() |
S Joos, A Miksch, J Szecsenyi, B Wieseler, U Grouven, T Kaiser, and A Schneider Montelukast as add-on therapy to inhaled corticosteroids in the treatment of mild to moderate asthma: a systematic review Thorax, May 1, 2008; 63(5): 453 - 462. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. D. Bateman, S. S. Hurd, P. J. Barnes, J. Bousquet, J. M. Drazen, M. FitzGerald, P. Gibson, K. Ohta, P. O'Byrne, S. E. Pedersen, et al. Global strategy for asthma management and prevention: GINA executive summary Eur. Respir. J., January 1, 2008; 31(1): 143 - 178. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Peters-Golden and W. R. Henderson Jr. Leukotrienes N. Engl. J. Med., November 1, 2007; 357(18): 1841 - 1854. [Full Text] [PDF] |
||||
![]() |
J. Travers, S. Marsh, M. Williams, M. Weatherall, B. Caldwell, P. Shirtcliffe, S. Aldington, and R. Beasley External validity of randomised controlled trials in asthma: to whom do the results of the trials apply? Thorax, March 1, 2007; 62(3): 219 - 223. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Barnes Spoilt for Choice? Am. J. Respir. Crit. Care Med., February 1, 2007; 175(3): 208 - 209. [Full Text] [PDF] |
||||
![]() |
The American Lung Association Asthma Clinical Rese Clinical Trial of Low-Dose Theophylline and Montelukast in Patients with Poorly Controlled Asthma Am. J. Respir. Crit. Care Med., February 1, 2007; 175(3): 235 - 242. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kraft, C. B. Cairns, M. C. Ellison, J. Pak, C. Irvin, and S. Wenzel Improvements in Distal Lung Function Correlate With Asthma Symptoms After Treatment With Oral Montelukast Chest, December 1, 2006; 130(6): 1726 - 1732. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Humbert The Right Tools at the Right Time Chest, July 1, 2006; 130(1_suppl): 29S - 40S. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H. Green, C. E. Brightling, S. McKenna, B. Hargadon, N. Neale, D. Parker, C. Ruse, I. P. Hall, and I. D. Pavord Comparison of asthma treatment given in addition to inhaled corticosteroids on airway inflammation and responsiveness Eur. Respir. J., June 1, 2006; 27(6): 1144 - 1151. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. A. Biernacki, S. A. Kharitonov, H. M. Biernacka, and P. J. Barnes Effect of Montelukast on Exhaled Leukotrienes and Quality of Life in Asthmatic Patients Chest, October 1, 2005; 128(4): 1958 - 1963. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P. Currie, D. K. C. Lee, and P. Srivastava Long-Acting Bronchodilator or Leukotriene Modifier as Add-on Therapy to Inhaled Corticosteroids in Persistent Asthma? Chest, October 1, 2005; 128(4): 2954 - 2962. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Busse and M. Kraft Cysteinyl Leukotrienes in Allergic Inflammation: Strategic Target for Therapy Chest, April 1, 2005; 127(4): 1312 - 1326. [Abstract] [Full Text] [PDF] |
||||
![]() |
G.P. Currie, P. Srivastava, O.J. Dempsey, and D.K.C. Lee Therapeutic modulation of allergic airways disease with leukotriene receptor antagonists QJM, March 1, 2005; 98(3): 171 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Jayaram, M. Duong, M. M. M. Pizzichini, E. Pizzichini, D. Kamada, A. Efthimiadis, and F. E. Hargreave Failure of montelukast to reduce sputum eosinophilia in high-dose corticosteroid-dependent asthma Eur. Respir. J., January 1, 2005; 25(1): 41 - 46. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Riccioni, R. D. Vecchia, M. Castronuovo, C. Di Ilio, and N. D'Orazio Tapering Dose of Inhaled Budesonide in Subjects with Mild-to-Moderate Persistent Asthma Treated with Montelukast: A 16-Week Single-Blind Randomized Study Ann. Clin. Lab. Sci., January 1, 2005; 35(3): 285 - 289. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. D. Sin, J. Man, H. Sharpe, W. Q. Gan, and S. F. P. Man Pharmacological Management to Reduce Exacerbations in Adults With Asthma: A Systematic Review and Meta-analysis JAMA, July 21, 2004; 292(3): 367 - 376. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Bahna Is It Time to Reduce Our Phobia of Inhaled Corticosteroids? Pediatrics, June 1, 2004; 113(6): 1813 - 1814. [Full Text] [PDF] |
||||
![]() |
E. S. Mendes, M. A. Campos, A. Hurtado, and A. Wanner Effect of Montelukast and Fluticasone Propionate on Airway Mucosal Blood Flow in Asthma Am. J. Respir. Crit. Care Med., May 15, 2004; 169(10): 1131 - 1134. [Abstract] [Full Text] [PDF] |
||||
![]() |
D.-W. Perng, H.-Y. Huang, Y.-C. Lee, and R.-P. Perng Leukotriene Modifier vs Inhaled Corticosteroid in Mild-to-Moderate Asthma: Clinical and Anti-inflammatory Effects Chest, May 1, 2004; 125(5): 1693 - 1699. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Snyder, P. D. Blanc, P. P. Katz, E. H. Yelin, and M. D. Eisner Leukotriene Modifier Use and Asthma Severity: How Is a New Medication Being Used by Adults With Asthma? Arch Intern Med, March 22, 2004; 164(6): 617 - 622. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Jalba, G. J. Rodrigo, C. Rodrigo, C. A. Camargo Jr., M.-P. Malice, S. A. Green, and T. F. Reiss Intravenous Montelukast in Acute Asthma Am. J. Respir. Crit. Care Med., January 1, 2004; 169(1): 130 - 131. [Full Text] |
||||
![]() |
Y. Cai, L. Bjermer, and T. S. Halstensen Bronchial Mast Cells Are the Dominating LTC4S-Expressing Cells in Aspirin-Tolerant Asthma Am. J. Respir. Cell Mol. Biol., December 1, 2003; 29(6): 683 - 693. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Bjermer, H. Bisgaard, J. Bousquet, L. M Fabbri, A. P Greening, T. Haahtela, S. T Holgate, C. Picado, J. Menten, S B. Dass, et al. Montelukast and fluticasone compared with salmeterol and fluticasone in protecting against asthma exacerbation in adults: one year, double blind, randomised, comparative trial BMJ, October 18, 2003; 327(7420): 891. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. P. Currie, D. K. C. Lee, K. Haggart, C. E. Bates, and B. J. Lipworth Effects of Montelukast on Surrogate Inflammatory Markers in Corticosteroid-treated Patients with Asthma Am. J. Respir. Crit. Care Med., May 1, 2003; 167(9): 1232 - 1238. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M Ducharme Inhaled glucocorticoids versus leukotriene receptor antagonists as single agent asthma treatment: systematic review of current evidence BMJ, March 22, 2003; 326(7390): 621 - 621. [Abstract] [Full Text] [PDF] |
||||
![]() |
N C Thomson and M Shepherd Leukotriene receptor antagonists as add-on therapy for adults with asthma Thorax, March 1, 2003; 58(3): 190 - 192. [Abstract] [Full Text] [PDF] |
||||
![]() |
M J Vaquerizo, P Casan, J Castillo, M Perpina, J Sanchis, V Sobradillo, A Valencia, H Verea, J L Viejo, C Villasante, et al. Effect of montelukast added to inhaled budesonide on control of mild to moderate asthma Thorax, March 1, 2003; 58(3): 204 - 210. [Abstract] [Full Text] [PDF] |
||||
![]() |
D B Price, D Hernandez, P Magyar, J Fiterman, K M Beeh, I G James, S Konstantopoulos, R Rojas, J A van Noord, M Pons, et al. Randomised controlled trial of montelukast plus inhaled budesonide versus double dose inhaled budesonide in adult patients with asthma Thorax, March 1, 2003; 58(3): 211 - 216. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. O'Sullivan, M. Akveld, C. M. Burke, and L. W. Poulter Effect of the Addition of Montelukast to Inhaled Fluticasone Propionate on Airway Inflammation Am. J. Respir. Crit. Care Med., March 1, 2003; 167(5): 745 - 750. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. M. Abraham Of Mice and Men Am. J. Respir. Cell Mol. Biol., January 1, 2003; 28(1): 1 - 4. [Full Text] [PDF] |
||||
![]() |
F. Kanniess, K. Richter, S. Bohme, R.A. Jorres, and H. Magnussen Montelukast versus fluticasone: effects on lung function, airway responsiveness and inflammation in moderate asthma Eur. Respir. J., October 1, 2002; 20(4): 853 - 858. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. G. Miller and A. F. Shorr Unnecessary Use of Placebo Controls: The Case of Asthma Clinical Trials Arch Intern Med, August 12, 2002; 162(15): 1673 - 1677. [Full Text] [PDF] |
||||
![]() |
O. J. Dempsey, S. J. Fowler, A. Wilson, G. Kennedy, and B. J. Lipworth Effects of Adding Either a Leukotriene Receptor Antagonist or Low-Dose Theophylline to a Low or Medium Dose of Inhaled Corticosteroid in Patients With Persistent Asthma* Chest, July 1, 2002; 122(1): 151 - 159. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. M Ducharme Anti-leukotrienes as add-on therapy to inhaled glucocorticoids in patients with asthma: systematic review of current evidence BMJ, June 29, 2002; 324(7353): 1545 - 1545. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. J Mazur Montelukast moderately decreased asthma symptoms in children with persistent asthma Evid. Based Med., May 1, 2002; 7(3): 77 - 77. [Full Text] [PDF] |
||||
![]() |
E. O. Meltzer, R. F. Lockey, B. F. Friedman, C. Kalberg, S. Goode-Sellers, S. Srebro, L. Edwards, K. Rickard, and Fluticasone Propionate Clinical Research Study Gro Efficacy and Safety of Low-Dose Fluticasone Propionate Compared With Montelukast for Maintenance Treatment of Persistent Asthma Mayo Clin. Proc., May 1, 2002; 77(5): 437 - 445. [Abstract] [PDF] |
||||
![]() |
F. G. Miller and A. F. Shorr Ethical Assessment of Industry-Sponsored Clinical Trials* : A Case Analysis Chest, April 1, 2002; 121(4): 1337 - 1342. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Lipworth and C. M. Jackson Bronchodilator Reversibility to Albuterol Predicts Bronchodilator Response to Salmeterol Chest, April 1, 2002; 121(4): 1382 - 1382. [Full Text] [PDF] |
||||
![]() |
P.J. Barnes Scientific rationale for inhaled combination therapy with long-acting {beta}2-agonists and corticosteroids Eur. Respir. J., January 1, 2002; 19(1): 182 - 191. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-E. DAHLEN, K. MALMSTROM, E. NIZANKOWSKA, B. DAHLEN, P. KUNA, M. KOWALSKI, W. R. LUMRY, C. PICADO, D. D. STEVENSON, J. BOUSQUET, et al. Improvement of Aspirin-Intolerant Asthma by Montelukast, a Leukotriene Antagonist . A Randomized, Double-Blind, Placebo-Controlled Trial Am. J. Respir. Crit. Care Med., January 1, 2002; 165(1): 9 - 14. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Botkin, E. Clayton, R. Nelson, B. Wilfond, M. A. Munger, F. G. Miller, A. F. Shorr, L. Friedman Ross, S. J. Fowler, B. J. Lipworth, et al. Salmeterol and Inhaled Corticosteroids in Patients With Persistent Asthma JAMA, December 26, 2001; 286(24): 3075 - 3078. [Full Text] [PDF] |
||||
![]() |
H. A M Kerstjens, H. J Groen, and W. van der Bij Recent advances: Respiratory medicine BMJ, December 8, 2001; 323(7325): 1349 - 1353. [Full Text] [PDF] |
||||
![]() |
N. Roche, T. Lepage, J. Bourcereau, and P. Terrioux Guidelines versus clinical practice in the treatment of chronic obstructive pulmonary disease Eur. Respir. J., December 1, 2001; 18(6): 903 - 908. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. C. KIPS and R. A. PAUWELS Long-acting Inhaled beta 2-Agonist Therapy in Asthma Am. J. Respir. Crit. Care Med., September 15, 2001; 164(6): 923 - 932. [Full Text] [PDF] |
||||
![]() |
B. Knorr, L. M. Franchi, H. Bisgaard, J. H. Vermeulen, P. LeSouef, N. Santanello, T. M. Michele, T. F. Reiss, H. H. Nguyen, and D. L. Bratton Montelukast, a Leukotriene Receptor Antagonist, for the Treatment of Persistent Asthma in Children Aged 2 to 5 Years Pediatrics, September 1, 2001; 108(3): e48 - 48. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. N. BLACK, F. BLASI, C. R. JENKINS, R. SCICCHITANO, G. D. MILLS, A. R. RUBINFELD, R. E. RUFFIN, P. R. MULLINS, J. DANGAIN, B. C. COOPER, et al. Trial of Roxithromycin in Subjects with Asthma and Serological Evidence of Infection with Chlamydia pneumoniae Am. J. Respir. Crit. Care Med., August 15, 2001; 164(4): 536 - 541. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Fish, E. Israel, J. J. Murray, A. Emmett, R. Boone, S. W. Yancey, and K. A. Rickard Salmeterol Powder Provides Significantly Better Benefit Than Montelukast in Asthmatic Patients Receiving Concomitant Inhaled Corticosteroid Therapy Chest, August 1, 2001; 120(2): 423 - 430. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. V. Bourdet and D. Williams Management Considerations for Chronic Asthma Journal of Pharmacy Practice, April 1, 2001; 14(2): 108 - 125. [Abstract] [PDF] |
||||
![]() |
H. Bisgaard Leukotriene Modifiers in Pediatric Asthma Management Pediatrics, February 1, 2001; 107(2): 381 - 390. [Abstract] [Full Text] |
||||
![]() |
O J Dempsey Leukotriene receptor antagonist therapy Postgrad. Med. J., December 1, 2000; 76(902): 767 - 773. [Abstract] [Full Text] |
||||
![]() |
W. W. Busse A 47-Year-Old Woman With Severe Asthma JAMA, November 1, 2000; 284(17): 2225 - 2233. [Full Text] [PDF] |
||||
![]() |
G. Ménard and E. Y. Bissonnette Priming of Alveolar Macrophages by Leukotriene D4 . Potentiation of Inflammation Am. J. Respir. Cell Mol. Biol., October 1, 2000; 23(4): 572 - 577. [Abstract] [Full Text] |
||||
![]() |
A. Reicin, R. White, S. F. Weinstein, A. F. Finn Jr, H. Nguyen, I. Peszek, L. Geissler, B. C. Seidenberg, and for the Montelukast/Loratadine Study Group Montelukast, a Leukotriene Receptor Antagonist, in Combination With Loratadine, a Histamine Receptor Antagonist, in the Treatment of Chronic Asthma Arch Intern Med, September 11, 2000; 160(16): 2481 - 2488. [Abstract] [Full Text] |
||||
![]() |
D. A. Stempel, M. LAVIOLETTE, K. MALMSTROM, and T. F. REISS MONTELUKAST ADDED TO INHALED BECLOMETHASONE IN TREATMENT OF ASTHMA Am. J. Respir. Crit. Care Med., July 1, 2000; 162(1): 331 - 332. [Full Text] |
||||
![]() |
Are Inhaled Steroids and Leukotriene Antagonists Additive for Asthma? Journal Watch (General), January 7, 2000; 2000(107): 5 - 5. [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Cell Mol. Biol. |